Osteopenia in children with cerebral palsy can be treated with oral alendronate
β Scribed by Muhammet Sukru Paksu; Sebahattin Vurucu; Abdulbaki Karaoglu; Alper Ozgur Karacalioglu; Ahmet Polat; Ozgur Yesilyurt; Bulent Unay; Ridvan Akin
- Publisher
- Springer
- Year
- 2011
- Tongue
- English
- Weight
- 139 KB
- Volume
- 28
- Category
- Article
- ISSN
- 0256-7040
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Many children with cerebral palsy (CP) suffer from feeding disorders. Twenty children with spastic CP and 20 neurologically normal children (age range 6.2-12.9 years) were monitored with ultrasound imaging of the oral cavity synchronized with surface electromyographic (EMG) recordings of masseter an
## Abstract ## Background The efficacy of oral acyclovir, a purine nucleoside analogue with activity against human herpes viruses, is limited as a result of its low bioavailability. Valacyclovir, the Lβvalyl ester of acyclovir, has been developed as a proβdrug to improve the bioavailability. The a